Last update 20 Dec 2025

YKYY018

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious Diseases
Active Indication
Respiratory Syncytial Virus Infections
Inactive Indication-
Originator Organization
Yuekang Pharmaceutical Group Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.
Active Organization
Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.Yuekang Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with YKYY018
ChiCTR2500113839
/ Not yet recruitingNot ApplicableIIT
A randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of YKYY018 for Inhalation Solution in healthy participants
CTR20254796
/ Not yet recruitingPhase 1
一项评价YKYY018雾化吸入剂在健康成人参与者中安全性、耐受性和药代动力学特征的随机、双盲、安慰剂对照、单次及多次给药剂量递增的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled, single-dose and multiple-dose escalation phase I clinical study evaluating the safety, tolerability, and pharmacokinetic characteristics of YKYY018 nebulized inhaler in healthy adult participants.
100 Clinical Results associated with YKYY018
Login to view more data
100 Translational Medicine associated with YKYY018
Login to view more data
100 Patents (Medical) associated with YKYY018
Login to view more data
100 Deals associated with YKYY018
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsPhase 1
China
Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.Beijing Yuekang Kechuang Pharmaceutical Technology Co., Ltd.
09 Dec 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free